Bisphosphonate-Induced Osteonecrosis of the Jaw: Comparison of Disease Extent on Contrast-Enhanced MR Imaging, [¹⁸F] Fluoride PET/CT, and Conebeam CT imaging

REFERENCES

1. 1.↵
   1. Cheng A,
   2. Mavrokokki A,
   3. Carter G,
   4. et al

   . The dental implications of bisphosphonates and bone disease. Aust Dent J 2005;50:S4–13

   PubMedWeb of Science
2. 2.↵
   1. Marx RE

   . Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115–17

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Mavrokokki T,
   2. Cheng A,
   3. Stein B,
   4. et al

   . Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 2007;65:415–23

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Hewitt C,
   2. Farah CS

   . Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review. J Oral Pathol Med 2007;36:319–28

   PubMedWeb of Science
5. 5.↵
   1. Durie BG,
   2. Katz M,
   3. Crowley J

   . Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005;353:99–102, discussion 99–102

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Morag Y,
   2. Morag-Hezroni M,
   3. Jamadar DA,
   4. et al

   . Bisphosphonate-related osteonecrosis of the jaw: a pictorial review. Radiographics 2009;29:1971–84

   CrossRefPubMed
7. 7.↵
   1. Tyndall DA,
   2. Rathore S

   . Cone-beam CT diagnostic applications: caries, periodontal bone assessment, and endodontic applications. Dent Clin North Am 2008;52:825–41, vii

   CrossRefPubMed
8. 8.↵
   1. García-Ferrer L,
   2. Bagan JV,
   3. Martinez-Sanjuan V,
   4. et al

   . MRI of mandibular osteonecrosis secondary to bisphosphonates. AJR Am J Roentgenol 2008;190:949–55

   CrossRefPubMed
9. 9.↵
   1. Grant FD,
   2. Fahey FH,
   3. Packard AB,
   4. et al

   . Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med 2008;49:68–78

   Abstract/FREE Full Text
10. 10.↵
    1. Donati OF,
    2. Zanetti M,
    3. Nagy L,
    4. et al

    . Is dynamic gadolinium enhancement needed in MR imaging for the preoperative assessment of scaphoidal viability in patients with scaphoid nonunion? Radiology 2011;260:808–16

    CrossRefPubMed
11. 11.↵
    1. Fox MG,
    2. Stephens T,
    3. Jarjour WN,
    4. et al

    . Contrast-enhanced magnetic resonance imaging positively impacts the management of some patients with rheumatoid arthritis or suspected RA. J Clin Rheumatol 2012;18:15–22

    CrossRefPubMed
12. 12.↵
    1. Carlson ER,
    2. Basile JD

    . The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2009;67:85–95

    PubMed
13. 13.↵
    1. Arce K,
    2. Assael LA,
    3. Weissman JL,
    4. et al

    . Imaging findings in bisphosphonate-related osteonecrosis of jaws. J Oral Maxillofac Surg 2009;67:75–84

    CrossRefPubMedWeb of Science
14. 14.↵
    1. De Vos W,
    2. Casselman J,
    3. Swennen GR

    . Cone-beam computerized tomography (CBCT) imaging of the oral and maxillofacial region: a systematic review of the literature. Int J Oral Maxillofac Surg 2009;38:609–25

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Pauwels R,
    2. Stamatakis H,
    3. Bosmans H,
    4. et al

    . Quantification of metal artifacts on cone beam computed tomography images. Clin Oral Implants Res 2011 Dec 15. [Epub ahead of print]
16. 16.↵
    1. Loubele M,
    2. Bogaerts R,
    3. Van Dijck E,
    4. et al

    . Comparison between effective radiation dose of CBCT and MSCT scanners for dentomaxillofacial applications. Eur J Radiol 2009;71:461–68

    CrossRefPubMed
17. 17.↵
    1. Kalender WA,
    2. Kyriakou Y

    . Flat-detector computed tomography (FD-CT). Eur Radiol 2007;17:2767–79

    CrossRefPubMed
18. 18.↵
    1. Stockmann P,
    2. Hinkmann FM,
    3. Lell MM,
    4. et al

    . Panoramic radiograph, computed tomography or magnetic resonance imaging: which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. Clin Oral Investig 2010;14:311–17

    CrossRefPubMed
19. 19.↵
    1. Allen MR,
    2. Burr DB

    . Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know. Bone 2011;49:56–65

    CrossRefPubMed
20. 20.↵
    1. Hutchinson M,
    2. O'Ryan F,
    3. Chavez V,
    4. et al

    . Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure. J Oral Maxillofac Surg 2010;68:2232–40

    CrossRefPubMed
21. 21.↵
    1. Frost ML,
    2. Blake GM,
    3. Park-Holohan SJ,
    4. et al

    . Long-term precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism. J Nucl Med 2008;49:700–07

    Abstract/FREE Full Text